Expression of hepatitis B virus X protein in transgenic mice

World Journal of Gastroenterology

Volumn 9, Issue 1, 2003, Pages 112-116

  Xiong, Jun ^a   Yao, Yu Cheng ^a   Zi, Xiao Yuan ^a   Li, Jian Xiu ^a   Wang, Xin Min ^a   Ye, Xu Ting ^a   Zhao, Shu Min ^a   Yan, Yong Bi ^a   Yu, Hong Yu ^b   Hu, Yi Ping ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; REAGENT; RECOMBINANT DNA; RESTRICTION ENDONUCLEASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CODING; CYTOPLASM; DNA TRANSFECTION; DNA VECTOR; EUKARYOTIC CELL; GENE; GENETIC ENHANCEMENT; GENOMICS; HELA CELL; HEPATITIS B VIRUS; IMMUNOGOLD ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; LIFE CYCLE; LIVER; LIVER CELL; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; OPEN READING FRAME; PLASMID; POLYMERASE CHAIN REACTION; PRONUCLEUS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSGENIC MOUSE; WESTERN BLOTTING; ZYGOTE;

EID: 12244263538     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i1.112     Document Type: Article

References (58)

1. Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985; 317: 489-495
2. Ganem D, Varmus HE. The molecular biology of the hepatitis B viruses. Annu Rev Biochem 1987; 56: 651-693
3. Gan RB, Chu MJ, Shen LP, Qian SW, Li ZP. The complete nucleotide sequence of the cloned DNA of hepatitis B virus subtype adr in pADR-1. Sci Sin B 1987; 30: 507-521
4. Seeger C, Mason WS. Hepatitis B virus biology. Micro Mol Bio Rev 2000; 64: 51-68
5. Stuyver LJ, Locarnini SA, Lok A, Richman DD, Carman WF, Dienstag JL, Schinazi RF. Nomenclature for antiviral-resistance human hepatitis B virus mutations in the polymerase region. Hepatol 2001; 33: 751-757
6. Wu X, Zhu L, Li ZP, Koshy R, Wang Y. Functional organization of enhancer (EN) of hepatitis B virus. Virology 1992; 191: 490-494
7. Chisari FV, Ferran C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29-60
8. Chisari FV. Viruses, immunity, and cancer: Lessons from hepatitis B. Am J Patho 2000; 156: 1117-1132
9. Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A, Castagnetta LA. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N Y Acad Sci 2002; 963: 13-20
10. Arbuthnot P, Kew M. Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol 2001; 82: 77-100
11. Honda M, Kaneko S, Kawai H, Shirota Y, Kobayashi K. Differential gene expression between chronic hepatitis B and C hepatic lesion. Gastroenterology 2001; 120: 955-966
12. Liu H, Wang Y, Zhou Q, Gui SY, Li X. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China. World J Gastroenterol 2002; 8: 480-482
13. Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue Q, Chen J, Gao DM,, Bao WH. Establishment of cell clones with different metastatic potential from the mestatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 2001; 7: 630-636
14. Cao XY, Liu J, Lian ZR, Clayton M, Hu JL, Zhu MH, Feitelson M. Differentially expressed genes in hepatocellular carcinoma induced by woodchuck hepatitis B virus in mice. World J Gastroenterol 2001; 7: 575-578
15. Lee JH, Ku JL, Park YJ, Lee KU, Kim WH, Park JG. Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA. World J Gastroenterol 1999; 5: 289-295
16. Madden CR, Finegold MJ, Slagle BL. Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J Virol 2001; 75: 3851-3858
17. Koike K, Moriya K, Yotsuyanagi H, Iino S, Kurokawa K. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J Clin Invest 1994; 94: 44-49
18. Shih WL, Kuo ML, Chuang SE, Cheng AL, Doong SL. Hepatitis B virus X protein inhibits transforming growth factor-α-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Bio Chem 2000; 275: 25858-25864
19. Benn J, Schneider RJ. Hepatitis B virus HBx protein deregulates cell ocycle checkpoint controls. Proc Natl Acad Sci 1995; 92: 11215-11219
20. Ogden SK, Lee KC, Barton MC. Hepatitis B viral transactivator HBx alleviates p53-mediated repression of α-fetoprotein gene expression. J Bio Chem 2000; 275: 27806-27814
21. Su F, Theodosis CN, Schneider RJ. Role of NK-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J Virol 2001; 75: 215-225
22. Diao J, Garces R, Richardson CD. X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev 2001; 12: 189-205
23. Kaneko S, Miller RH. X-region-specific transcript in mammalian hepatitis B virus-infected liver. J Virol 1988; 62: 3979-3984
24. Terradillos O, Pollicino T, Lecouer H, Tripodi M, Gougeon ML, Tiollais P, Buendia MA. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 1998; 17: 2115-2123
25. Su F, Schneider RJ. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci U S A 1997; 94: 8744-8749
26. Murakami S. Hepatitis B virus X protein: A multifunctional viral regulator. J Gastroenterol 2001; 36: 651-660
27. Feitelson MA, Duan LX. Hepatitis B virus x antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol 1997; 150: 1141-1157
28. Miyatake S, Yokota T, Lee F, Arai K. Structure of the chromosomal gene for murine interleukin 3. Proc Natl Acad Sci USA 1985; 82: 316-320
29. Lambert JF, Benoit BO, Colvin GA, Carlson J, Delville Y, Quesenberry PJ. Quick sex determination of mouse fetuses. J Neurosci Method 2000; 95: 127-132
30. Rall GF, Lawrence DM, Patterson CE. The application of transgenic and knockout mouse technology for the study of viral pathogenesis. Virology 2000; 271: 220-226
31. Koike K. Hepatocarcinogenesis in hepatitis viral infection: Lessons from transgenic mouse studies. J Gastroenterol 2002; 37 (suppl13): 55-64
32. Chen XS, Wang GJ, Cai X, Yu HY, Hu YP. Inhibition of hepatitis B virus by oxymatrine in vivo. World J Gastroentero 2001; 7: 49-52
33. Aragona E, Burk RD, Ott M, Shafritz DA, Gupta S. Cell type-specific mechanisms regulate hepatitis B virus transgene expression in liver and other organs. J Pathol 1996; 180: 441-449
34. Xu Z, Yen TS, Wu L, Madden CR, Tan W, Slagle BL, Ou JH. Enhancement of hepatitis B virus replication by its X protein in transgenic mice. J Virol 2002; 76: 2579-2584
35. Guidotti LG, Matzke B, Schaller H, Chisari FV. High-level hepatitis B virus replication in transgenic mice. J Virol 1995; 69: 6158-6169
36. Zhu HZ, Cheng GX, Chen JQ, Kuang SY, Cheng Y, Zhang XL, Li HD, Xu SF, Shi JQ, Qian GS, Gu JR. Preliminary study on the production of transgenic mice harboring hepatitis B virus X gene. World J Gastroenterol 1998; 4: 536-539
37. Chemin I, Ohgaki H, Chisari FV, Wild CP. Altered expression of hepatic carcinogen metabolizing enzymes with liver injury in HBV transgenic mouse lineages expressing various amounts of hepatitis B surface antigen. Liver 1999; 19: 81-87
38. Schweizer J, Valenza-Schaerly P, Goret F, Pourcel C. Control of expression and methylation of a hepatitis B virus transgene by strain-specific modifiers. DNA Cell Biol 1998; 17: 427-435
39. Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317-320
40. Hu YP, Hu WJ, Zheng WC, Li JX, Dai DS, Wang XM, Zhang SZ, Yu HY, Sun W, Hao GR. Establishment of transgenic mouse harboring hepatitis B virus (adr subtype) genomes. World J Gastroenterol 2001; 7: 111-114
41. Hu YP, Yao YC, Li JX, Wang XM, Li H, Wang ZH, Lei ZH. The cloning of 3′-truncated preS/S gene from HBV genomic DNA and its expression in transgenic mice. World J Gastroenterol 2000; 6: 734-737
42. Ganem D. The X files-one step closer to closure. Science 2001; 294: 2299-2300
43. Bouchard MJ, Wang LH, Schneider RJ. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 2001; 294: 2376-2378
44. Yun C, Um HR, Jin YH, Wang JH, Lee MO, Park S, Lee JH, Cho H. NF-kappaB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival. Cancer Lett 2002; 184: 97-104
45. Bergametti F, Sitterlin D, Transy C. Turnover of hepatitis B virus X protein is regulated by damaged DNA-binding complex. J Virol 2002; 76: 6495-6501
46. Li J, Xu Z, Zheng Y, Johnson DL, Ou JH. Regulation of hepatocyte nuclear factor 1 activity by wild-type and mutant hepatitis B virus X proteins. J Virol 2002; 76: 5875-5881
47. Han HJ, Jung EY, Lee WJ, Jang KL. Cooperative repression of cyclin-dependent kinase inhibitor p21 gene expression by hepatitis B virus X protein and hepatitis C virus core protein. FEBS Lett, 2002; 518: 169-172
48. Wang XZ, Jiang XR, Chen XC, Chen ZX, Li D, Lin JY, Tao QM. Seek protein which can interact with hepatitis B virus X protein from human liver cDNA library by yeast two-hybrid system. World J Gastroenterol 2002; 8: 95-98
49. Guo SP, Wang WL, Zhai YQ, Zhao YL. Expression of nuclear factor-kappa B in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus. World J Gastroenterol 2001; 7:340-344
50. Lee S, Tarn C, Wang WH, Chen S, Hullinger RL, Andrisani OM. Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines. J Biol Chem 2002; 277: 8730-8740
51. Qiao L, Leach K, McKinstry R, Gilfor D, Yacoub A, Park JS, Grant S, Hylemon PB, Fisher PB, Dent P. Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression. Hepatology 2001; 34: 906-917
52. Waris G, Huh KW, Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol 2001; 21: 7721-7730
53. Nag A, Datta A, Yoo K, Bhattacharyya D, Chakrabortty A, Wang X, Slagle BL, Costa RH, Raychaudhuri P. DDB2 induces nuclear accumulation of the hepatitis B virus X protein independently of binding to DDB1. J Virol 2001; 75: 10383-10392
54. Lin-Marq N, Bontron S, Leupin O, Strubin M. Hepatitis B virus X protein interferes with cell viability through interaction with the p127-kDa UV-damaged DNA-binding protein. Virology 2001; 287: 266-274
55. Tarn C, Lee S, Hu Y, Ashendel C, Andrisani OM. Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes. J Biol Chem 2001; 276: 34671-34680
56. Jaitovich-Groisman I, Benlimame N, Slagle BL, Perez MH, Alpert L, Song DJ, Fotouhi-Ardakani N, Galipeau J, Alaoui-Jamali MA. Transcriptional regulation of the TFIIH transcription repair components XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissue. J Biol Chem 2001; 276: 14124-14132
57. Pan J, Duan LX, Sun BS, Feitelson MA. Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa B. J Gen Virol 2001; 82: 171-182
58. Sitterlin D, Bergametti F, Transy C. UVDDB p127-binding modulates activities and intracellular distribution of hepatitis B virus X protein. Oncogene 2000; 19: 4417-4426